MyHizentra™ Infusion Manager App

Under the direction of your prescriber, the MyHizentra Infusion Manager app can help patients / caregivers schedule infusions, get reminders about upcoming infusions, and record details of each infusion.

Your Digital Hizentra Therapy & Infusion Manager

Introducing a way to stay on track with your therapy! The MyHizentra Infusion Manager app is here to help you schedule your infusions, alert you when it's time to infuse, and simplify the infusion tracking process.

Mobile app that allows patients to set up custom alerts for self-administration treatments

Custom Self-Infusion Reminders

Rather than just receiving a single reminder on a single device, the MyHizentra Infusion Manager app can send you reminders on all cloud-synced devices (desktop, laptop, mobile phone) as part of your regular calendar. This makes it easier to remember and keep your infusion appointments.

Infusion Manager app that assists in managing infusions with a customizable schedule and preferences

Flexible & Designed With You in Mind

Like Hizentra itself, the Infusion Manager app is flexible and designed to fit your lifestyle. Whether you are managing your own infusions or those of a loved one, you can adjust the schedule and the reminder times for your convenience. You can even reschedule the infusion time if you are aware of a conflict during the scheduled time. Adjustments to your schedule should only be made under the supervision of your prescriber.

Multiple users can access the app from one device, but each user has a separate profile within the app. This makes it simple, since the infusion schedule and preferences can be customized for each user.

Mobile app that stores a detailed record of infusions

Keep a Detailed Record of Every Infusion

The app makes it easy for you to record your infusions, including scanning the QR code of each vial and giving you a place to write notes about each infusion. The infusion journal records the date, time, infusion sites, how you were feeling, any other medications you are taking, and other notes. You'll be able to review the digital record of your past infusions at any time, which will make it convenient to discuss your infusion experiences with your doctor during appointments. Also, in the event of a vial recall or alert, your entire infusion history can be searched for the affected lot.

Apple, the Apple logo, iPad, and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. By clicking on the App Store link above, you will be taken to a website hosted by Apple.

Android and Google Play are trademarks of Google Inc. By clicking on the Google Play link above, you will be taken to a site hosted by Google Inc.

Important Safety Information
Expand

Important Safety Information

WARNING: Thrombosis (blood clots) can occur with immune globulin products, including Hizentra. Risk factors can include: advanced age, prolonged immobilization, a history of blood clotting or hyperviscosity (blood thickness), use of estrogens, installed vascular catheters, and cardiovascular risk factors.

If you are at high risk of blood clots, your doctor will prescribe Hizentra at the minimum dose and infusion rate practicable and will monitor for signs of clotting events and hyperviscosity. Always drink sufficient fluids before infusing Hizentra.

See your doctor for a full explanation, and the full prescribing information for complete boxed warning.

Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, is a prescription medicine used to treat:

  • Primary immune deficiency (PI) in patients 2 years and older
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) in adults

Treatment with Hizentra might not be possible if your doctor determines you have hyperprolinemia (too much proline in the blood), or are IgA-deficient with antibodies to IgA and a history of hypersensitivity. Tell your doctor if you have previously had a severe allergic reaction (including anaphylaxis) to the administration of human immune globulin. Tell your doctor right away or go to the emergency room if you have hives, trouble breathing, wheezing, dizziness, or fainting. These could be signs of a bad allergic reaction.

Inform your doctor of any medications you are taking, as well as any medical conditions you may have had, especially if you have a history of diseases related to the heart or blood vessels, or have been immobile for some time. Inform your physician if you are pregnant or nursing, or plan to become pregnant.

Infuse Hizentra under your skin only; do not inject into a blood vessel. Self-administer Hizentra only after having been taught to do so by your doctor or other healthcare professional, and having received dosing instructions for treating your condition.

Immediately report to your physician any of the following symptoms, which could be signs of serious adverse reactions to Hizentra:

  • Reduced urination, sudden weight gain, or swelling in your legs (possible signs of a kidney problem).
  • Pain and/or swelling or discoloration of an arm or leg, unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, or numbness/weakness on one side of the body (possible signs of a blood clot).
  • Bad headache with nausea; vomiting; stiff neck; fever; and sensitivity to light (possible signs of meningitis).
  • Brown or red urine; rapid heart rate; yellowing of the skin or eyes; chest pains or breathing trouble; fever over 100°F (possible symptoms of other conditions that require prompt treatment).

Hizentra is made from human blood. The risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent and its variant (vCJD), cannot be completely eliminated.

The most common side effects in the clinical trials for Hizentra include redness, swelling, itching, and/or bruising at the infusion site; headache; chest, joint or back pain; diarrhea; tiredness; cough; rash; itching; fever, nausea, and vomiting. These are not the only side effects possible. Tell your doctor about any side effect that bothers you or does not go away.

Before receiving any vaccine, tell immunizing physician if you have had recent therapy with Hizentra, as effectiveness of the vaccine could be compromised.

Please see full prescribing information for Hizentra, including boxed warning and the patient product information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Collapse
Patient/Caregiver Resources Hizentra Infusion App
CSL Behring
Hizentra is manufactured by CSL Behring AG and distributed by CSL Behring LLC.
Hizentra® and MyHizentra® are registered trademarks of CSL Behring AG.
Biotherapies for Life® is a registered trademark of CSL Behring LLC.
CSL Behring AssuranceSM, IgIQSM, and Premier StartSM are service marks of CSL Behring LLC.
Voice2Voice® is a registered trademark of CSL Behring GmbH.
© 2018 CSL Behring LLC. The product information presented on this site is intended for US residents only. HIZ-0316-MAR18